AXIL: reviveprocare.com Company Buyout Price

High digital marketing expenditures and declining pharmacy demand are weighing on AXIL Brands, Inc. (AXIL) profits, while the business valuation stands at 30.37. This price chart illustrating trading dynamics complements data regarding the company's bet on bio-formulas and the automation of eco-factories. The brand is strengthening its position by integrating clinical standards into daily skin and hair care to increase customer trust.

AXIL (AXIL Brands Inc) Total Company Value history from 11/23/2025 to 10/27/2026

AXIL Brands (AXIL) - metric breakdowns and financial figures

- price and consensus price forecast:

Share Price AXIL Brands Inc|AXIL - Analyst Consensus Forecast

- market capitalization data:

Market Capitalization AXIL Brands|AXIL - Total Company Value

- book capitalization data:

Net Assets per Single Share AXIL Brands|AXIL - Company Book Value|Market Capitalization to Net Assets reviveprocare.com|AXIL - Company Total Assets

- debt and liquidity data:

All Debt to Shareholders' Equity Ratio AXIL Brands, Inc.|AXIL - Long-Term Debt to Capital|Short-Term Debt to Capital AXIL Brands Inc|AXIL - Company Debts|Debt to Net Assets Ratio AXIL Brands

Comprehensive company analysis:AXIL Brands, Inc. (AXIL)

The proprietary brand protection of AXIL Brands, Inc. (AXIL) creates a sustainable market barrier, impacting the overall asset value. The Enterprise Value, equal to 30.37, combines market capitalization with net debt to determine the actual buyout price of the business. This metric allows an investor to assess the financial burden relative to liquidity. Analysis of the enterprise value chart reveals a long-term trend, filtering out market noise. This is critical under strict regulatory control of consumer goods.

Competitor analysis for AXIL Brands, Inc.

Business Value Krystal Biotech Inc KRYS|Enterprise Value APGE (Apogee Pharma)|ARQT: Company Buyout Price|Vericel Corporation (VCEL) - Total Company Value|ORKA (orukatx.com) - Total Company Value|Total Company Value Sanara MedTech, Inc. SMTI|Full Business Value DBV Technologies SA|Solesence Inc (SLSN) - Enterprise Value|Value Adjusted for Debt and Cash journeymedicalcorp.com (DERM)|Enterprise Value FBRX (Forte Biosciences, Inc.)|empro.my - Enterprise Value|Total Company Value Sol-Gel Technologies Ltd. (SLGL)|MDCX: Value Adjusted for Debt and Cash|VRCA (verrica.com) - Total Company Value|Hoth Therapeutics (HOTH) - Real Price to Acquire Entire Company|BFRI (Biofrontera, Inc.) - Enterprise Value|Enterprise Value VYNE Therapeutics Inc (VYNE)|Sonoma Pharmaceuticals (SNOA) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash QNRX (quoinpharma.com)|Total Company Value AZTR|Dermata Corp - Company Buyout Price|Elevai Labs Inc. - Total Company Value|RVNC - Enterprise Value